Alembic Pharmaceuticals Ltd
Madhu Edara is an experienced biochemist currently working at Granules India Limited since December 2019 and serving as a Senior Research Scientist at Alembic Pharmaceuticals Limited since December 2017, focusing on analytical method validation and technology transfer for dermaceutical products. Previous experience includes a role as a Research Associate at Mylan from August 2015 to September 2016, where analytical development for liposomes and novel drug delivery systems was undertaken, and as a Trainee Executive at SHILPA MEDICARE LTD from December 2012 to August 2014, concentrating on analytical research and development for injectable formulations. Madhu Edara holds a Master of Pharmacy degree in Pharmaceutical Analysis and Regulatory Affairs from Acharya Nagarjuna University and a Bachelor's degree in Pharmacy from Tamil Nadu Doctor M.G.R. Medical University.
This person is not in the org chart
This person is not in any offices
Alembic Pharmaceuticals Ltd
9 followers
Alembic Pharmaceuticals Limited is a pharmaceutical company. The Company is engaged developing formulations and active pharmaceutical ingredients (API). The Company focuses on anti-infective, analgesic and, cough and cold therapies. It also focuses on therapies, such as cardiology, diabetes, gynecology, gastrointestinal, orthopedic, dermatology and ophthalmology. Its APIs include independent manufacturing blocks for Macrolides, non-steroidal anti-inflammatory drugs (NSAIDs) and other drugs. The Company offers international and domestic formulations. Under domestic formulation, it offers Branded Formulations and Generic formulations. Its domestic formulation include Roxid, Zofix, Althrocin, Tellzy AH, Revas H, Lactonic, Folinal, Gestofit, Glisen 1/2, Glimser 1/2, Veldrop, Azithral, Brinzemic and Neolap. Its generic formulations include Cetral, Ephedrex CD, Sicor, Worid, Alcephin, Alcizon, Baciclox, Comeba, Furobid, O Win Suspension, O win T, Silomag Gel, Pentab, Aginal AT and Pyremol.